Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)

Opportunity details

Agency

National Institutes of Health

Notice type

Federal Grant

Original posted

May 4, 2026

Last updated

August 30, 2026

Notice ID

grant-361026

Summary

The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.

Summary fields are from official SAM.gov or Grants.gov structured data. CaptureIQ does not republish full solicitation or grant text.

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations: Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement are not allowed.

Eligible applicant categories

• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Native American tribal organizations (other than Federally recognized tribal governments)
• Public housing authorities/Indian housing authorities
• Small businesses
• Private institutions of higher education
• Public and State controlled institutions of higher education
• State governments
• City or township governments
• Native American tribal governments (Federally recognized)
• Independent school districts
• Special district governments
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• County governments
• For profit organizations other than small businesses
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Official Grants.gov eligibility information. Listed categories are not a determination that an organization qualifies.

Funding and program

Assistance Listing

93.855

Funding instrument

Grant

Cost sharing

Not required

Estimated total program funding

4,000,000

Expected number of awards

5 (government estimate, not a guaranteed count)

Official modification date

May 4, 2026

Estimated total program funding is the government figure for the whole program, not an individual award ceiling. The expected number of awards is a government estimate, not a guaranteed count. These figures are estimates, not guaranteed funding.

Related Federal Opportunities

• NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)National Institutes of Health · Due Sep 10, 20
• Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)National Institutes of Health · Due Sep 30, 20
• NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)National Institutes of Health · Due Aug 17, 20
• Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)National Institutes of Health · Due May 28, 20